Related Experiment Video
Updated: Aug 8, 2026
08:40
Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
Methylation mechanisms in pituitary tumorigenesis
W E Farrell1, D J Simpson, S J Frost
1Centre for Cell and Molecular Medicine, School of Postgraduate Medicine, Keele University, North Staffordshire Hospital, Stoke-on-Trent, UK. w.e.farrell@keele.ac.uk
Endocrine-Related Cancer
|March 24, 2000
Summary
Aberrant DNA methylation silences tumor suppressor genes (TSGs) like p16/CDKN2A in pituitary tumors. Reactivating these silenced genes with demethylating agents offers a promising therapeutic strategy.
Area of Science:
- Molecular Biology
- Cancer Genetics
- Epigenetics
Background:
- Aberrant DNA methylation of tumor suppressor genes (TSGs) is a hallmark of many cancers, leading to gene silencing.
- The p16/CDKN2A gene, crucial in tumor suppression, frequently undergoes methylation in pituitary tumors, correlating with protein expression loss.
- CpG sites are mutation hotspots, and altered methylation patterns can drive genetic instability and allelic loss.
Purpose of the Study:
- To investigate the role of DNA methylation in pituitary tumor development and gene silencing.
- To explore the potential of demethylating agents as a therapeutic strategy for tumors with aberrant methylation.
Main Methods:
- Utilized a mouse corticotroph cell line (AtT20) as a model system.
- Conducted transfection studies with the p16/CDKN2A gene, including in vitro methylation of CpG sites.
- Examined the effect of demethylating agents on gene expression in tumor cell lines.
Main Results:
- Ectopic expression of p16/CDKN2A in AtT20 cells restored growth control.
- In vitro methylation of p16/CDKN2A constructs reversed these growth-inhibitory effects.
- Demethylating agents can induce expression of previously silenced genes in tumor cells.
Conclusions:
- DNA methylation is a key mechanism for silencing TSGs in pituitary tumors, contributing to tumorigenesis.
- Reactivating epigenetically silenced TSGs represents a viable therapeutic approach for cancers, including pituitary tumors.
- Further research into pharmacological interventions and the mechanisms of abnormal methylation is warranted.
Related Concept Videos
01:46Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
02:30Genomic Imprinting and Inheritance
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:37Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
01:17Phase II Reactions: Methylation Reactions
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...